Saubens, France

Stëphane Poigny

This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Dermo-Cosmetique. Active years: 2013.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Stëphane Poigny in Cosmetic Chemistry

Introduction

Stëphane Poigny is a notable inventor based in Saubens, France. He has made significant contributions to the field of cosmetic chemistry, particularly through his innovative work on methylene furanone derivatives. His research focuses on the application of these derivatives as photoprotecting, antioxidant, and depigmentation agents in cosmetic and dermatological compositions.

Latest Patents

Stëphane Poigny holds 1 patent related to his work. The patent details the use of methylene furanone derivatives and outlines methods for their preparation. Specifically, it involves a Suzuki-Miyaura coupling reaction from corresponding dibromofuranone derivatives. Additionally, the invention describes a method of preparation that includes a coupling reaction of 2-methoxy-furan derivatives with a ketone, followed by dehydration.

Career Highlights

Stëphane Poigny is associated with Pierre Fabre Dermo-Cosmetique, a company renowned for its commitment to dermatological and cosmetic products. His work has contributed to the development of innovative solutions that enhance skin health and beauty.

Collaborations

Stëphane collaborates with esteemed colleagues such as Estelle Marchal and Philippe Uriac. Their combined expertise fosters a creative environment that drives forward-thinking research in cosmetic applications.

Conclusion

Stëphane Poigny's contributions to cosmetic chemistry through his innovative patents highlight the importance of research in developing effective skincare solutions. His work continues to influence the industry and improve the quality of cosmetic products available today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…